| Sample | Title | Value | Rank |
|---|
| GSM303966 | SLE-7 #4 @12wks, asymptomatic (-2077090517) | 673.504 | 96 |
| GSM303972 | SLE-7 #3 @12wks, asymptomatic (-2077090523) | 638.365 | 96 |
| GSM303986 | SLE-7 #2 @12wks, asymptomatic (-2077090529) | 639.296 | 96 |
| GSM303991 | SLE-7 #1 @12wks, asymptomatic (-2077090535) | 647.781 | 96 |
| GSM303961 | SLE-7 #1 @36wks, asymptomatic on treatment with sirolimus (-2101366109) | 563.241 | 95 |
| GSM303979 | SLE-7 #3 @36wks, asymptomatic on treatment with sirolimus (-2101365196) | 668.309 | 97 |
| GSM303985 | SLE-7 #2 @36wks, asymptomatic on treatment with sirolimus (-2101365652) | 653.475 | 96 |
| GSM303971 | SLE-7 #2 @36wks, diseased/symptomatic (-2101366115) | 418.44 | 93 |
| GSM303973 | SLE-7 #1 @36wks, diseased/symptomatic (-2101366147) | 691.926 | 96 |
| GSM303980 | SLE-7 #3 @36wks, diseased/symptomatic (-2102085829) | 510.681 | 95 |
| GSM303962 | SLE-7 #3 @42wks, asymptomatic on treatment with sirolimus (-2101365164) | 950.269 | 98 |
| GSM303978 | SLE-7 #2 @42wks, asymptomatic on treatment with sirolimus (-2102085846) | 612.346 | 96 |
| GSM303982 | SLE-7 #1 @42wks, asymptomatic on treatment with sirolimus (-2101365170) | 573.511 | 96 |
| GSM303965 | SLE-7 #2 @42wks, diseased/symptomatic (-2102085823) | 719.149 | 97 |
| GSM303968 | SLE-7 #1 @42wks, diseased/symptomatic (-2101365185) | 620.31 | 96 |
| GSM303981 | SLE-7 #3 @42wks, diseased/symptomatic (-2101365176) | 489.378 | 95 |